JP2022551751A5 - - Google Patents
Info
- Publication number
- JP2022551751A5 JP2022551751A5 JP2022522586A JP2022522586A JP2022551751A5 JP 2022551751 A5 JP2022551751 A5 JP 2022551751A5 JP 2022522586 A JP2022522586 A JP 2022522586A JP 2022522586 A JP2022522586 A JP 2022522586A JP 2022551751 A5 JP2022551751 A5 JP 2022551751A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025171716A JP2026028257A (ja) | 2019-10-17 | 2025-10-10 | 血液障害を処置するための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962916492P | 2019-10-17 | 2019-10-17 | |
| US62/916,492 | 2019-10-17 | ||
| PCT/US2020/056121 WO2021076991A1 (en) | 2019-10-17 | 2020-10-16 | Compositions and methods for treating blood disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171716A Division JP2026028257A (ja) | 2019-10-17 | 2025-10-10 | 血液障害を処置するための組成物及び方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022551751A JP2022551751A (ja) | 2022-12-13 |
| JP2022551751A5 true JP2022551751A5 (https=) | 2023-10-24 |
| JPWO2021076991A5 JPWO2021076991A5 (https=) | 2023-10-24 |
| JP7809056B2 JP7809056B2 (ja) | 2026-01-30 |
Family
ID=75538375
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522586A Active JP7809056B2 (ja) | 2019-10-17 | 2020-10-16 | 血液障害を処置するための組成物及び方法 |
| JP2025171716A Pending JP2026028257A (ja) | 2019-10-17 | 2025-10-10 | 血液障害を処置するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171716A Pending JP2026028257A (ja) | 2019-10-17 | 2025-10-10 | 血液障害を処置するための組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240109957A1 (https=) |
| EP (1) | EP4045084A4 (https=) |
| JP (2) | JP7809056B2 (https=) |
| KR (1) | KR20220083737A (https=) |
| CN (1) | CN114746118A (https=) |
| AU (1) | AU2020365132A1 (https=) |
| BR (1) | BR112022007051A2 (https=) |
| CA (1) | CA3157873A1 (https=) |
| IL (1) | IL292186A (https=) |
| MX (1) | MX2022004287A (https=) |
| WO (1) | WO2021076991A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015006507A1 (en) | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| CA3195798A1 (en) * | 2020-10-16 | 2022-04-21 | Ted Yednock | Compositions and methods for treating blood disorders |
| WO2023114763A1 (en) * | 2021-12-13 | 2023-06-22 | Annexon, Inc. | Anti-complement factor c1q antibodies with single binding arms and uses thereof |
| CN118259018B (zh) * | 2024-03-21 | 2024-10-29 | 泰州市人民医院 | C1s抗体制备及其在ITP诊断中的应用 |
| CN119371528B (zh) * | 2024-10-30 | 2025-06-24 | 泰州市人民医院 | 一种C1q抗体及其应用、一种抑制补体经典途径活化的药剂及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009258063B2 (en) * | 2007-06-21 | 2014-09-25 | Macrogenics, Inc. | BCR-complex-specific antibodies and methods of using same |
| KR101615935B1 (ko) * | 2007-12-14 | 2016-04-28 | 노보 노르디스크 에이/에스 | 인간 ｎｋｇ2ｄ에 대한 항체 및 그것의 용도 |
| BR112014013205A2 (pt) * | 2011-12-01 | 2020-10-27 | Protevobio, Inc. | proteína de fusão, seu uso e seu método de produção, composição farmacêutica, ácido nucleico, e kit |
| KR102339315B1 (ko) * | 2012-06-18 | 2021-12-15 | 오메로스 코포레이션 | 다양한 질환 및 장애의 치료를 위해 masp-1 및/또는 masp-2 및/또는 masp-3를 억제하는 조성물 및 방법 |
| WO2015006507A1 (en) * | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| CN104231085B (zh) * | 2013-09-05 | 2017-03-15 | 复旦大学附属肿瘤医院 | 靶向特异性补体系统抑制剂、其制备方法及应用 |
| HUE070383T2 (hu) * | 2014-11-05 | 2025-06-28 | Annexon Inc | Humanizált C1Q anti-komplement faktor antitestek és alkalmazásaik |
| US9382321B2 (en) * | 2014-11-26 | 2016-07-05 | Adventis Health System/Sunbelt, Inc. | Effector-deficient anti-CD32A antibodies |
| WO2017091719A1 (en) * | 2015-11-24 | 2017-06-01 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
-
2020
- 2020-10-16 WO PCT/US2020/056121 patent/WO2021076991A1/en not_active Ceased
- 2020-10-16 US US17/769,180 patent/US20240109957A1/en active Pending
- 2020-10-16 EP EP20877082.6A patent/EP4045084A4/en active Pending
- 2020-10-16 MX MX2022004287A patent/MX2022004287A/es unknown
- 2020-10-16 CA CA3157873A patent/CA3157873A1/en active Pending
- 2020-10-16 CN CN202080079840.5A patent/CN114746118A/zh active Pending
- 2020-10-16 JP JP2022522586A patent/JP7809056B2/ja active Active
- 2020-10-16 KR KR1020227015552A patent/KR20220083737A/ko active Pending
- 2020-10-16 BR BR112022007051A patent/BR112022007051A2/pt unknown
- 2020-10-16 AU AU2020365132A patent/AU2020365132A1/en active Pending
-
2022
- 2022-04-12 IL IL292186A patent/IL292186A/en unknown
-
2025
- 2025-10-10 JP JP2025171716A patent/JP2026028257A/ja active Pending